Innovative financing for health: What is truly innovative?

Rifat Atun, Felicia Marie Knaul, Yoko Akachi, Julio Frenk

Research output: Contribution to journalComment/debate

45 Scopus citations

Abstract

Development assistance for health has increased every year between 2000 and 2010, particularly for HIV/AIDS, tuberculosis, and malaria, to reach US$26·66 billion in 2010. The continued global economic crisis means that increased external fi nancing from traditional donors is unlikely in the near term. Hence, new funding has to be sought from innovative fi nancing sources to sustain the gains made in global health, to achieve the health Millennium Development Goals, and to address the emerging burden from non-communicable diseases. We use the value chain approach to conceptualise innovative fi nancing. With this framework, we identify three integrated innovative fi nancing mechanisms-GAVI, Global Fund, and UNITAID-that have reached a global scale. These three fi nancing mechanisms have innovated along each step of the innovative fi nance value chain-namely resource mobilisation, pooling, channelling, resource allocation, and implementation-and integrated these steps to channel large amounts of funding rapidly to low-income and middle-income countries to address HIV/AIDS, malaria, tuberculosis, and vaccine-preventable diseases. However, resources mobilised from international innovative fi nancing sources are relatively modest compared with donor assistance from traditional sources. Instead, the real innovation has been establishment of new organisational forms as integrated fi nancing mechanisms that link elements of the fi nancing value chain to more eff ectively and effi ciently mobilise, pool, allocate, and channel fi nancial resources to low-income and middle-income countries and to create incentives to improve implementation and performance of national programmes. These mechanisms provide platforms for health funding in the future, especially as eff orts to grow innovative fi nancing have faltered. The lessons learnt from these mechanisms can be used to develop and expand innovative fi nancing from international sources to address health needs in low-income and middle-income countries.

Original languageEnglish (US)
Pages (from-to)2044-2049
Number of pages6
JournalThe Lancet
Volume380
Issue number9858
DOIs
StatePublished - Dec 2012
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Innovative financing for health: What is truly innovative?'. Together they form a unique fingerprint.

  • Cite this